Aspirin for primary prevention of coronary events.

被引:113
作者
Lauer, MS [1 ]
机构
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
关键词
D O I
10.1056/NEJMcp012672
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 45-year-old man with a strong family history of premature heart disease has no symptoms of coronary disease and has a normal electrocardiogram. A fasting lipid analysis reveals a total cholesterol level of 225 mg per deciliter (5.8 mmol per liter), a high-density lipoprotein cholesterol level of 35 mg per deciliter (0.9 mmol per liter), a triglyceride level of 150 mg per deciliter (1.7 mmol per liter), and a low-density lipoprotein cholesterol level of 160 mg per deciliter (4.1 mmol per liter). The man's resting systolic blood pressure is 125 mm Hg, and he has never taken any medications for hypertension. He is a nonsmoker and is physically active. Should he be advised to take aspirin to reduce his risk of coronary events?
引用
收藏
页码:1468 / 1474
页数:7
相关论文
共 52 条
[51]   Prevention of coronary heart disease in clinical practice:: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention [J].
Wood, D ;
De Backer, G ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Pyörälä, K .
ATHEROSCLEROSIS, 1998, 140 (02) :199-270
[52]  
Yusuf S, 2001, NEW ENGL J MED, V345, P494